Form 4: Intercontinental Exchange General Counsel Andrew Surdykowski Sells Shares Under 10b5-1 Plan

Andrew Surdykowski, General Counsel of Intercontinental Exchange, Inc., sold 1,898 shares of common stock at $136.66 per share on June 26, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On June 26, 2024, Andrew J Surdykowski, the General Counsel of Intercontinental Exchange, Inc. (ICE), sold 1,898 shares of ICE common stock.
• The sale was executed at a price of $136.66 per share.
• This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan established on December 5, 2023.
• Following the transaction, Surdykowski directly owns 46,815 shares, which includes 39,637 shares of common stock and 7,178 unvested performance-based restricted stock units (PSUs).
• The vesting of these PSUs is contingent upon performance metrics related to EBITDA and total shareholder return, with vesting dates extending into February 2027.
• Some PSUs are also tied to Deal Incentive Awards, with performance assessment and vesting potentially extending to December 2028.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The sale was conducted under a pre-arranged 10b5-1 trading plan, suggesting it was planned and not necessarily indicative of a change in the executive's outlook on the company. The document provides factual information without expressing any positive or negative sentiment.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which is generally viewed as a transparent and compliant method for insiders to sell shares.

Future Outlook

The vesting of performance-based restricted stock units (PSUs) is contingent upon future performance metrics related to EBITDA and total shareholder return, with vesting dates extending into February 2027. The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.

Industry Context

Insider sales are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects. Sales under 10b5-1 plans are generally less indicative of immediate concerns, as they are pre-scheduled.

Comparison to Industry Standards

• Comparing Surdykowski's transactions to those of other General Counsels in similar financial exchange companies (e.g., Nasdaq, CME Group) could provide context.
• Analyzing the frequency and size of insider sales across these companies can help determine if Surdykowski's activity is typical or unusual.
• Reviewing the vesting schedules and performance metrics of PSU grants in these companies can also offer a benchmark for comparison.

Stakeholder Impact

• The sale of shares by a high-ranking executive could potentially create uncertainty among shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates